Patents by Inventor Luke J. LEMAN

Luke J. LEMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMOTHERAPEUTIC REMODELING OF THE GUT MICROBIOME
    Publication number: 20220040255
    Abstract: The present invention provides methods for remodeling gut microbiome to a desired state. The invention also provides in vitro screening platform for identifying novel agents that can remodel dysfunctional gut microbiome.
    Type: Application
    Filed: September 26, 2019
    Publication date: February 10, 2022
    Inventors: Reza M. Ghadiri, Luke J. Leman, Poshen B. Chen, Yannan Zhao, Ali Torkamani, Audrey Black
  • Uses of cyclic peptides for treating and preventing atherosclerosis
    Patent number: 10092620
    Abstract: The present invention provides cyclic compounds that are useful in preventing or treating atherosclerosis or related disorders. The invention also provides therapeutic methods for treating or preventing various diseases or disorders associated with or mediated by atherosclerosis. Further provided in the invention are methods of screening for anti-atherosclerotic cyclic peptides with improved properties.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: October 9, 2018
    Assignee: The Scripps Research Institute
    Inventors: M. Reza Ghadiri, Luke J. Leman, Yannan Zhao, Bruce E. Maryanoff
  • Uses Of Cyclic Peptides For Treating And Preventing Atherosclerosis Uses of Cyclic Peptides for Treating and Preventing Atherosclerosis
    Publication number: 20160250280
    Abstract: The present invention provides cyclic compounds that are useful in preventing or treating atherosclerosis or related disorders. The invention also provides therapeutic methods for treating or preventing various diseases or disorders associated with or mediated by atherosclerosis. Further provided in the invention are methods of screening for anti-atherosclerotic cyclic peptides with improved properties.
    Type: Application
    Filed: April 2, 2014
    Publication date: September 1, 2016
    Inventors: M. Reza GHADIRI, Luke J. LEMAN, Yannan ZHAO, Bruce E. MARYANOFF